Erstellt von conna
Amgen Inc. diskutieren
Amgen Inc.
WKN: 867900 / Symbol: AMGN / Name: Amgen / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
353,05 €
3,52 %
Amgen (AMGN) had its "positive" rating reaffirmed by Royal Bank Of Canada.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by Oppenheimer Holdings, Inc. from $400.00 to $450.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $370.00 to $400.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by Robert W. Baird from $215.00 to $230.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by Bank of America Corporation from $312.00 to $317.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its "outperform" rating reaffirmed by Scotiabank.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by TD Cowen from $420.00 to $452.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen (AMGN) had its price target raised by UBS Group AG from $420.00 to $440.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Charles River Labs Intl diskutieren